Home/MapLight Therapeutics/Sarah B. Noonberg, M.D., Ph.D.
SB

Sarah B. Noonberg, M.D., Ph.D.

Chief Medical Officer

MapLight Therapeutics

Roles

Chief Medical OfficeratMapLight Therapeutics
Chief Medical Officer (Board of Directors)atNeurogene

MapLight Therapeutics Pipeline

DrugIndicationPhase
ML-007Social impairment in Autism Spectrum DisorderPhase 2
ML-104Treatment-resistant DepressionPreclinical
ML-225Cognitive impairment in Alzheimer's DiseasePreclinical
Undisclosed ProgramAnxiety DisordersDiscovery